跳至主要内容
临床试验/CTRI/2024/02/062196
CTRI/2024/02/062196招募中Unknown

Establishment and validation of a microfluidic 3D Cancer-on-Chip platform to study chemo and radio-sensitivity in advanced head and neck cancer patients. - NI

Sanjiban Chakrabarty0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • locally advanced HNSCC planned for treatment with definitive radiotherapy with or without concurrent chemotherapy. For recurrent patients, locoregional persistence or recurrence following definitive radiotherapy with or without chemotherapy. Metastatic recurrence could also be included, if biopsy is feasible.

排除标准

  • 1) Age above 70 years,
  • 2) Medically compromised,
  • 3) Low performance status,
  • 4) unwillingness to participate,
  • 5) Unwilling/unfit for tumor directed treatment for recurrent disease.

研究者

发起方
Sanjiban Chakrabarty

相似试验

Developing a novel in vitro Cancer-on-Chip platform... | 临床试验